Syndrome News and Research

RSS

TIM-family proteins also have ability to block release of HIV and other viruses

A family of proteins that promotes virus entry into cells also has the ability to block the release of HIV and other viruses, University of Missouri researchers have found.

26 Aug 2014

Actavis files ANDA for generic version of Neupro

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Rotigotine Extended-release Transdermal Film, 1 mg/24 hr, 2mg/24 hr, 3 mg/24hr, 4 mg/24 hr, 6mg/24hr, and 8 mg/24 hr.

25 Aug 2014

Highlights from the August issue of Mayo Clinic Health Letter

Here are highlights from the August issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required.

22 Aug 2014

State highlights: Calif. audit finds hospital payroll wrongdoing; Ill. plans Medicaid contraception boost; Minn. union vote

Audits of a state prison and psychiatric hospital detail hundreds of thousands of dollars in improper payments and financial problems, including outright payroll fraud, and medical staff and guards receiving questionable bonuses and holiday pay, according to reports released Wednesday (St. John, 8/20).

22 Aug 2014

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

Researchers in the United Kingdom have demonstrated that advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.

22 Aug 2014

Painkillers may not offer relief to people suffering from irritable bowel syndrome

University of Adelaide researchers have discovered that the immune system is defective in people suffering from irritable bowel syndrome, which is a major reason why sufferers have ongoing issues with pain.

21 Aug 2014

Regular blood transfusion therapy reduces recurrence of strokes in kids with sickle cell anemia

Vanderbilt-led research, as part of an international, multicenter trial, found regular blood transfusion therapy significantly reduces the recurrence of silent strokes and strokes in children with sickle cell anemia who have had pre-existing silent strokes, according to study results released today in the New England Journal of Medicine (NEJM).

21 Aug 2014

Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Almost one-third of acute heart failure syndrome patients seen in hospital emergency departments (EDs) in Florida and California during 2010 had ED visits during the following year, findings that suggest a lack of appropriate outpatient care.

21 Aug 2014

Metacognitive training benefits accumulate over time for schizophrenia patients

The benefits of metacognitive training to target cognitive biases persist for at least 3 years, with late additional benefits appearing more than 6 months after the intervention, shows research.

20 Aug 2014

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Some infants born with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have a more difficult time going through withdrawal than others, but the underlying reasons are not well understood.

20 Aug 2014

Rettsyndrome.Org awards $1.5M to advance translational research, support Neuro-Habilitation Program

The International Rett Syndrome Foundation now doing business as Rettsyndrome.org announces today that the Board of Trustees has awarded $1.5M to support 10 new grants to further translational research and launch of the neuro-habilitation therapeutic program, and fund clinical research.

19 Aug 2014

Another threat lies in the spread of Chikungunya virus, say experts

While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.

19 Aug 2014

Scientists develop algorithm to uncover genomic insertions and deletions involved in autism, OCD

With three billion letters in the human genome, it seems hard to believe that adding a DNA base here or removing a DNA base there could have much of an effect on our health.

18 Aug 2014

NTU research could lead to better treatment options for children suffering from leukaemia

A research team led by Nanyang Technological University scientists have made a key finding which is expected to open up improved treatment possibilities for children suffering from leukaemia.

15 Aug 2014

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Melbourne researchers have revealed the critical importance of highly specialised immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs.

14 Aug 2014

Findings open up improved treatment possibilities for children suffering from leukaemia

A research team led by Nanyang Technological University (NTU) scientists have made a key finding which is expected to open up improved treatment possibilities for children suffering from leukaemia.

14 Aug 2014

Reducing brain levels of tau protein effectively blocks development of childhood epilepsy

Researchers at the Gladstone Institutes have shown that reducing brain levels of the protein tau effectively blocks the development of disease in a mouse model of Dravet syndrome, a severe intractable form of childhood epilepsy.

14 Aug 2014

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Scientists from Queen Mary University of London have discovered mutations in genes that lead to childhood leukaemia of the acute lymphoblastic type - the most common childhood cancer in the world.

13 Aug 2014

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).

13 Aug 2014

Only 52% of women receive low-cost treatment to prevent babies death

A major international study of more than 303 000 births in 29 low-income and middle-income countries has found that only half (52%) of women who are eligible to receive a simple, effective, low-cost treatment to prevent death and disability in their newborn babies are getting it.

13 Aug 2014

Syndrome News and Research

TIM-family proteins also have ability to block release of HIV and other viruses

Actavis files ANDA for generic version of Neupro

Highlights from the August issue of Mayo Clinic Health Letter

State highlights: Calif. audit finds hospital payroll wrongdoing; Ill. plans Medicaid contraception boost; Minn. union vote

DNA testing for congenital cataracts can accurately diagnose diseases linked to childhood blindness

Painkillers may not offer relief to people suffering from irritable bowel syndrome

Regular blood transfusion therapy reduces recurrence of strokes in kids with sickle cell anemia

Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Metacognitive training benefits accumulate over time for schizophrenia patients

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Rettsyndrome.Org awards $1.5M to advance translational research, support Neuro-Habilitation Program

Another threat lies in the spread of Chikungunya virus, say experts

Scientists develop algorithm to uncover genomic insertions and deletions involved in autism, OCD

NTU research could lead to better treatment options for children suffering from leukaemia

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Findings open up improved treatment possibilities for children suffering from leukaemia

Reducing brain levels of tau protein effectively blocks development of childhood epilepsy

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Only 52% of women receive low-cost treatment to prevent babies death

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News